Biobank for male infertility specimens
Official title: Male Infertility and Assisted Reproductive Technologies Research Biobank
Run by Reproductive Medicine Associates of New Jersey · NCT06880302 · Data updated 2026-11-12
This study is collecting leftover sperm and tissue samples from men who have had fertility treatments to help improve understanding and treatment of male infertility in the future.
Quick facts
| Study type | Observational |
|---|---|
| Sex | Men only |
| Enrollment | 1000 (estimated) |
| Sponsor | Reproductive Medicine Associates of New Jersey Academic / other |
| Locations | 1 site (Basking Ridge, New Jersey) |
| Status | Recruiting |
| Started | March 4, 2025 |
| Main results expected | April 2032 |
| Study ends | December 2032 |
| Registry record updated | June 2, 2026 |
| Trial ID | NCT06880302 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates include males providing biological specimens for infertility treatments or sperm recipients using donor sperm.
✕Probably not a fit
Patients whose samples are quarantined for infectious diseases will not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This research aims to create a biobank of biological specimens from males that are used in the diagnosis and treatment of infertility and assisted reproductive technologies (ART). The biobank will include testicular tissue, sperm, and semen samples that are no longer needed for clinical purposes. These samples will be collected from men who have undergone procedures like IVF or IUI and will be utilized for future research on male infertility and ART. The goal is to enhance understanding and treatment options for male infertility.
Why it matters
Potential benefit: If successful, this biobank could lead to improved diagnostic and treatment strategies for male infertility.
How similar studies have gone: While biobanks for infertility research are common, the specific focus on male specimens in this context may provide novel insights.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Males providing testicular tissue, sperm, semen samples, discarded sperm preps for IUI/IVF/ICSI or the sperm recipient for those utilizing donor sperm, for cryopreservation at the respective site(s) for either clinical use or preservation Exclusion Criteria: * Samples that are quarantined or in isolation dewars for infectious diseases
Where it's running
-
Rmanj
Basking Ridge, New Jersey, United States Recruiting
Study contacts
- Study coordinator: Caroline Zuckerman, RN BSN
- Email: clinicalresearchteam@ivirma.com
- Phone: 9736562841
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
AI tool to analyze sperm and predict their ability to help IVF/ICSI succeed
This project will test an AI platform that analyzes semen samples from men providing sperm for IVF/ICSI to see if it can predict which samples have the best chance of supporting successful IVF/ICSI outcomes.
-
Differential Granulosa Cell Transcriptome Profiling to Predict Ongoing Pregnancy
Aiming to see if differences in granulosa cell gene activity can predict ongoing pregnancy in IVF and oocyte donation with PGT-A.
-
Detoxify for IVF: Cutting Everyday Pollutants to Help Infertility
This study tests a guide to help IVF patients reduce everyday environmental pollutants and sees if it lowers chemical exposure in urine, blood, and follicular fluid.
-
Carnitine and related supplements before IVF to see if they improve oocytes and embryos
This trial tests whether taking a supplement mix that includes L-carnitine before IVF helps improve the number and quality of eggs and embryos and the chances of pregnancy for women undergoing IVF.
-
Higher or lower starting FSH dose for good-prognosis IVF with PPOS
This trial tests whether starting IVF stimulation with 225 IU or 300 IU of FSH improves oocyte and embryo outcomes in good-prognosis women using PPOS.
-
Correlation between PLC zeta measurements and semen parameters in male infertility
This study tests whether levels of the sperm protein PLCζ in semen relate to standard semen quality measures in men facing infertility.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.